logo-loader
AIM:FARN

Faron Pharmaceuticals Ltd

Market:
AIM
Market Cap:
£136.19 m
Price
291.00 GBX
Change
0.34%
52 weeks high
595.00
52 weeks low
79.00

In brief

Faron is a clinical stage biopharmaceutical company developing novel treatments for medical conditions with significant unmet needs. The Company currently has a pipeline focusing on acute organ traumas, vascular damage and cancer immunotherapy.

Insight Widest with the analysis, Proactive gives perspectives that others don't.

If you want to hit it big (or fail spectacularly), speculate in resource stocks and biotechs

One has to kiss a lot of frogs before one finds oneself puckering up to a prince

on 1/1/20